Many therapeutically relevant proteins, like IgG antibodies, are highly complex, multimeric glycoproteins that are difficult to express in microbial systems and thus usually produced in mammalian host cells. During the past two decades, stable mammalian expression technologies have made huge progress resulting in highly increased speed of cell line development and yield of manufacturing processes. Here, we give an overview of technologies that are applied at different stages of state-of-the-art cell line development processes for biomanufacturing. © 2012 Springer Science+Business Media, LLC.
CITATION STYLE
Jostock, T., & Knopf, H. P. (2012). Mammalian stable expression of biotherapeutics. Methods in Molecular Biology, 899, 227–238. https://doi.org/10.1007/978-1-61779-921-1_15
Mendeley helps you to discover research relevant for your work.